Dinner & Clinical Update: This program will share information about a treatment option for myelodysplastic syndromes including an overview of MDS, ineffective erythropoiesis, the pivotal phase 3 trial design, efficacy, safety, dosing, and administration.

Speaker: Melhem Solh, MD Medical Director, Cellular Therapy Program, Northside Hospital